Real-time market signals
Hyperion machine-reads SEC filings, macro releases, FDA and clinical-trial data, patents, and dozens of other primary sources the moment they go public, then emails you the analysis in plain English: what happened, why it matters, and what would prove it wrong. Start with the free weekly research.
Alt-data pipeline coming soon
Want real-time, ad-free signals? Go Pro for $100/mo
No dashboards to watch. No charts to read. Hyperion does the work and emails you the result.
An 8-K hits SEC EDGAR, the FDA posts a trial result, a patent publishes, a macro print lands. Thousands of events fire every week, and most never make the news.
The second it's public, the model parses the document against the company's prior filings and street consensus, and decides whether it actually moves the thesis.
If it matters, a plain-English email lands in your inbox: the call, the read, the levels, and the one thing that would prove it wrong.
Hyperion Signal
Today · 9:47 AM ET
The read
A 9:12 AM 8-K discloses a 20-year power agreement with a hyperscale data-center customer at pricing roughly 30% above CEG's existing contract book. Consensus models haven't repriced the backlog; desks are still anchored to last quarter's guidance. Expect estimate revisions to chase the filing.
This is a Hyperion signal. Pro members get it the moment it fires; free members get a curated set in the weekly research email.
A few more from the feed
Management buried it in the Q&A, but ad-engine bookings are re-accelerating two quarters ahead of the model. The print hasn't caught up to the call.
The CFO resigns twelve days before earnings and full-year guidance is quietly withdrawn in the same filing. Two red flags, one document.
A fund with a strong security track record opened a $480M position last quarter. Not a trigger on its own, but worth watching for confirmation.
Gross margin compressed 380bps while inventory swelled 24%, a demand air-pocket the guidance never flagged. The Street's numbers haven't moved yet.
Illustrative examples of the kind of research Hyperion produces. Not investment advice or a recommendation to buy or sell any security.
Signals fire the moment the data does, not after it has been through three newsletters and a podcast. By the time it's consensus, you're already in.
Every signal explains what happened, why it matters, and the level that would prove it wrong. No black box, no jargon, no vibes.
SEC filings, macro and rates data, FDA and clinical-trial feeds, patents, and government and regulatory records, machine-read the second they're public. Not sentiment, not chatter.
Start free with the weekly research email. Upgrade to Pro for every signal the moment it fires.
Free
$0 / forever
A weekly email of curated research.
Pro
$100 / month
Every signal, the moment it fires.